PH
Philogen
PHLOG.MI·BITSiena ITFounded 1996200 employees
Small CapbiotechPublicOncology
Platform: F8-IL2 Immuno-cytokine
Market Cap
$0.5B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (PHLOG.MI)
Loading PHLOG.MI stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevisacituzumab | PHL-4830 | Preclinical | 1 | GLP-1R | MesoAtopic Derm | ||
| PHL-685 | PHL-685 | Approved | 4 | USP1 | CholangiocarcinomaEwing Sarcoma |
SEC Filings & Financial Documents
SEC filings are not available for BIT-listed companies.
Philogen trades on BIT (IT). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)